Cargando…

Getting Near to “Closing the Gap” in the Pediatric Age Group for the First Personalized Treatment of Cystic Fibrosis

Detalles Bibliográficos
Autor principal:	van Koningsbruggen-Rietschel, Silke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2021
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924585/ https://www.ncbi.nlm.nih.gov/pubmed/33113333 http://dx.doi.org/10.1164/rccm.202010-3848ED

Ejemplares similares

Impact of COVID-19 on people with cystic fibrosis
por: Colombo, Carla, et al.
Publicado: (2020)

Diabetes in Cystic Fibrosis: Multicenter Screening Results Based on Current Guidelines
por: Scheuing, Nicole, et al.
Publicado: (2013)

Reduced neutrophil elastase inhibitor elafin and elevated transforming growth factor-β(1) are linked to inflammatory response in sputum of cystic fibrosis patients with Pseudomonas aeruginosa
por: Thomassen, Jan C., et al.
Publicado: (2021)

The effect of TGF-β(1) polymorphisms on pulmonary disease progression in patients with cystic fibrosis
por: Trojan, T., et al.
Publicado: (2022)

Protecting clinical trials in cystic fibrosis during the SARS-CoV-2 pandemic: risks and mitigation measures
por: van Koningsbruggen-Rietschel, Silke, et al.
Publicado: (2021)

High Variability in Oral Glucose Tolerance among 1,128 Patients with Cystic Fibrosis: A Multicenter Screening Study
por: Scheuing, Nicole, et al.
Publicado: (2014)

From the infant to the geriatric patient—Strategies for inhalation therapy in asthma and chronic obstructive pulmonary disease
por: Hagmeyer, Lars, et al.
Publicado: (2023)

Closing the Execution Gap: How Great Leaders and Their Companies Get Results
por: Lepsinger, Richard
Publicado: (2010)

Getting up close and personal with UK genomics and beyond
por: Beck, Stephan
Publicado: (2018)

433: Rationale and design of an international multicenter prospective study to evaluate serologic immune responses to SARS-CoV-2 infection in persons living with cystic fibrosis: The CAR-CF study
por: Hernandez, R., et al.
Publicado: (2021)

Inhaled dry powder alginate oligosaccharide in cystic fibrosis: a randomised, double-blind, placebo-controlled, crossover phase 2b study
por: van Koningsbruggen-Rietschel, Silke, et al.
Publicado: (2020)

EVALUATION OF NUTRITIONAL STATUS IN PATIENTS WITH CYSTIC FIBROSIS ACCORDING TO AGE GROUP
por: Neri, Lenycia de Cassya Lopes, et al.
Publicado: (2018)

Identification of Critical Windows of Metabolic Programming of Metabolism and Lung Function in Male Offspring of Obese Dams
por: Dinger, Katharina, et al.
Publicado: (2020)

SARS-CoV-2 disrupts clinical research: the role of a rare disease-specific trial network
por: van Koningsbruggen-Rietschel, Silke, et al.
Publicado: (2020)

235: COVID-19 vaccination in individuals with cystic fibrosis at a pediatric cystic fibrosis center
por: Elson, E., et al.
Publicado: (2021)

Personalized or Precision Medicine? The Example of Cystic Fibrosis
por: Marson, Fernando A. L., et al.
Publicado: (2017)

The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Cuthbertson, Leah, et al.
Publicado: (2021)

Medications used in pediatric cystic fibrosis population
por: Alves, Stella Pegoraro, et al.
Publicado: (2018)

Getting near the top?
Publicado: (1984)

Assessing Infertility Literacy and Knowledge Gaps Among Patients with Cystic Fibrosis
por: Rahman, Farah, et al.
Publicado: (2023)

The Gap in Big Data: Getting to Wellbeing, Strengths, and a Whole-person Perspective
por: Monsen, Karen A., et al.
Publicado: (2015)

Closing the Gap
Publicado: (1924)

Hyperpharmacotherapy in ageing cystic fibrosis patients: The first report of an atypical hip fracture
por: Al-Azzani, W.A.K., et al.
Publicado: (2015)

Perception of first respiratory infection with Pseudomonas aeruginosa by people with cystic fibrosis and those close to them: an online qualitative study
por: Palser, Sally C, et al.
Publicado: (2016)

Sequential analysis of surfactant, lung function and inflammation in cystic fibrosis patients
por: Griese, Matthias, et al.
Publicado: (2005)

Mycobacterium Simiae Infection in a Person With Cystic Fibrosis
por: FitzMaurice, Thomas S, et al.
Publicado: (2020)

The Equitable Implementation of Cystic Fibrosis Personalized Medicines in Canada
por: Shemie, Genevieve, et al.
Publicado: (2021)

Surfactant Protein A in Cystic Fibrosis: Supratrimeric Structure and Pulmonary Outcome
por: Griese, Matthias, et al.
Publicado: (2012)

Getting closer: compassion training increases feelings of closeness toward a disliked person
por: Cernadas Curotto, Patricia, et al.
Publicado: (2023)

DNase and atelectasis in non-cystic fibrosis pediatric patients
por: Hendriks, Tom, et al.
Publicado: (2005)

Sleep-disordered breathing in cystic fibrosis pediatric subjects
por: Lumertz, Magali Santos, et al.
Publicado: (2019)

Severe Human Bocavirus Infection, Germany
por: Körner, Robert Walter, et al.
Publicado: (2011)

A weak signaler gets in close
por: Robinson, Richard, et al.
Publicado: (2008)

Closing the stop gap
por: Czakon, Michal, et al.
Publicado: (2014)

Closing the treatment gap
por: Thirunavukarasu, M.
Publicado: (2011)

Closing the Communication Gap
por: Harrington, H, et al.
Publicado: (2017)

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR): CLOSED AND OPEN STATE CHANNEL MODELS
por: Corradi, Valentina, et al.
Publicado: (2015)

Closing Human Reference Genome Gaps: Identifying and Characterizing Gap-Closing Sequences
por: Zhao, Tingting, et al.
Publicado: (2020)

Cystic Fibrosis Lung Disease in the Aging Population
por: Künzi, Lisa, et al.
Publicado: (2021)

Future Comorbidities in an Aging Cystic Fibrosis Population
por: Ticona, Javier Humberto, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l2r0cfbfv4j6s5cu1ucn5ch019